View
6
Download
0
Category
Preview:
Citation preview
CANACCORD GENUITY - GROWTH INVESTOR DAY JANUARY 22, 2019 - VANCOUVER BC
Charlie BachtellCEO & COFOUNDER
Joe CaltabianoPRESIDENT & COFOUNDER
CRESCO LABS TODAY’S PRESENTERS
2
DISCLAIMER
CRESCO LABS LEGAL DISCLAIMER
3
CRESCO LABS AGENDA
Today’s agenda
Our Company
Industry Trends
Cresco Competitive Advantage
Final Thoughts and Q&A
01
02
03
04
4
Our mission is to normalize and professionalize cannabis
CRESCO LABS OUR MISS ION
5
CRESCO LABS OUR COMPANY
CRESCO LABS IS A VERTICALLY INTEGRATED, MULTI-STATE OPERATOR
Cultivate& Manufacture
Brands& Products Retail
6
Wholesale Distribution
$3.0B
$2.1B
$2.0B
$2.0B
$1.8B
$1.5B
$1.0B
$0.6B
$0.5B
Curaleaf
Acreage
Cresco Labs
GTI
MedMen
Harvest
Green Growth
iAnthus
MPX
CRESCO LABS OUR COMPANY
Market Capitalization
Current Market Capitalization1
US dollars
#3
1 . CSE MARKET CAPITALIZATION AS OF JANUARY 14, 2019 7
ONE OF THE LARGEST OPERATORS IN THE U.S.
CRESCO LABS MACRO TRENDS
Key trends impacting the U.S. Cannabis
8
$80 Billion1
BY 2030
$24 Billion2
PROFIT
$196B
$114B$102B
$80B $75B $71B$57B $51B
$30B
Frozen
Alcohol
General Food
Cannabis
Home Care
Health
Refridgerated
Beverages
Beauty
Bill
ion
U.S
. Dol
lars
Cannabis will become a top consumer category by 20303
CRESCO LABS MACRO TRENDS
1 . COWEN CANNABIS ESTIMATE JANUARY 20192. INTERNAL ESTIMATE3. STATISTA 2017 RETAIL $ VOLUME AND COWEN CANNABIS ESTIMATE JANUARY 2019
9
THE OPPORTUNITYU.S. CANNABIS MARKET IS BECOMING EVEN MORE ATTRACTIVE
CRESCO LABS MACRO TRENDS
10
KEY MACRO TRENDS
REGULATION ACCESS EXPECTATIONS
CRESCO LABS KEY TRENDS
11
LEVELS OF COMPLEXITY
FEDERAL
NEW STATE
EXISTING STATE
MACRO TREND: REGULATIONMORE SUPPORT, BUT MORE COMPLEXITY
LEVELS OF SUPPORT
62% OF AMERICANS
74% OF MILLENNIALS
BI-PARTISAN LEGISLATION
PEW RESEARCH CENTER OCTOBER 2018
9 additional states looking to legalize in 2019CT, IL, MN, NH, NJ, NM, NY, RI, VT
More retail options and home delivery (DTC)
CRESCO LABS RETAIL LANDSCAPE
MACRO TREND: ACCESSRETAIL WILL BECOME UBIQUITOUS
12BDI STATES TO WATCH IN 2019
MACRO TREND: EXPECTATIONSEVOLUTION AND BLURRING OF CONSUMER NEEDS
HEAL WELLNESS PLAY
CRESCO LABS EVOLVING CONSUMER TRENDS
Promoting holistic health and wellness
Alternative for existing prescription products
Enhancing recreational occasions
Product Consistency &
Quality
Good/Better/BestAvailability
CRESCO LABS INDUSTRY EXPECTATIONS
MACRO TREND: EXPECTATIONSGREATER EXPECTATIONS OF THE INDUSTRY
14
Our opportunity to deliver growth
CRESCO LABS OUR OPPORTUNITY
15
Highly Effective Execution
Scale SellingSystem
House of Brands
Rapid Innovation Capabilities
THE CRESCO LABS ADVANTAGECAPABILITIES TO DRIVE LONG-TERM VALUE
WHAT WE DO HOW WE DO IT
Top-TierManagement Team
16CRESCO LABS COMPETIT IVE ADVANTAGE
Highly Effective Execution
Scale SellingSystem
House of Brands
Rapid Innovation Capabilities
THE CRESCO LABS ADVANTAGECAPABILITIES TO DRIVE LONG-TERM VALUE
WHAT WE DO HOW WE DO IT
Top-TierManagement Team
17CRESCO LABS COMPETIT IVE ADVANTAGE
UNMATCHED SUCCESS IN COMPETITIVE STATES
1. We win competitive licenses to open new markets
2. We acquire to enter existing markets
3. We get to market faster
4. We establish dominant positions
ACQUIRE ASSETS TO DRIVE GROWTH AND FOOTPRINT
OPERATIONAL FASTER THAN COMPETITORS
ACHIEVE 100% PENETRATION AND DOMINANT MARKET SHARE
CRESCO LABS HIGHLY EFFICIENT EXECUTION
WE EXECUTE
18
Highly Effective Execution
Scale SellingSystem
House of Brands
Rapid Innovation Capabilities
THE CRESCO LABS ADVANTAGECAPABILITIES TO DRIVE LONG-TERM VALUE
WHAT WE DO HOW WE DO IT
Top-TierManagement Team
19CRESCO LABS COMPETIT IVE ADVANTAGE
21 retail locations1
and counting
OWNED RETAIL
1 Includes licenses awarded for additional locations and pending transactions.20
+120 MillionRESIDENTS
+866 MillionTOURISTS
Average Revenue Per Square Foot
$6,500 $5,546 $2,951 $2,951
CRESCOLABS INTERNAL UNAUDITED ANALYSISCOSTAR RETAIL ANALYSIS JULY 2017
ATTRACTIVE RETAIL PERFORMANCE
21
+120 MillionRESIDENTS
+866 MillionTOURISTS
CURRENT OPERATIONS/LICENSED IN IL, PA, OH, NV, CA, AZTRANSACTION SUBJECT SOLELY TO REGULARITY. APPROVAL IN NY, MD, MA
PENDING LICENSE APPLICATION MI
MINDY’S EDIBLES LICENSING OPPORTUNITY IN OR, WA, CO, OK, NMTARGETING EXPANSION IN FL, NJ VA, CT
WE ARE BUILDING SCALE ACROSS THE U.S.
23
100%MARKET PENETRATION
+28%MARKET SHARE
100%MARKET PENETRATION
+30%MARKET SHARE
WE DRIVE WHOLESALE DISTRIBUTION EFFECTIVENESS
Highly Effective Execution
Scale SellingSystem
House of Brands
Rapid Innovation Capabilities
THE CRESCO LABS ADVANTAGECAPABILITIES TO DEFEND THE BUSINESS AND DRIVE LONG-TERM VALUE
WHAT WE DO HOW WE DO IT
Top-TierManagement Team
24CRESCO LABS COMPETIT IVE ADVANTAGE
We have taken a CPG approach to building brands
CRESCO LABS BRANDS
25
CRESCO LABS TAILORED BRAND PORTFOLIO
OVERALL MARKET CRESCOLABS BRANDS
CURRENT CONSUMER LANDSCAPE AND PORTFOLIO
MEDICINAL
WELLNESS/LIFESTYLE
HOLISTIC MEDICINE
REGULAR LIFESTYLE
CONNOISSEUR
CRESCO
REMEDI RESERVE
RELIEF
RELIABLETRUST
REWARD
26
27
28
R I SE REFRESH REST
29
30
Highly Effective Execution
Scale SellingSystem
House of Brands
Rapid Innovation Capabilities
THE CRESCO LABS ADVANTAGECAPABILITIES TO DEFEND THE BUSINESS AND DRIVE LONG-TERM VALUE
WHAT WE DO HOW WE DO IT
Top-TierManagement Team
31CRESCO LABS COMPETIT IVE ADVANTAGE
CRESCO LABS RAPID INNOVATION CAPABIL IT IES
RETAILINSIGHTS
DESIGN &DEVELOP
TEST &VALIDATE
OUR CAPABILITIES ALLOW US TO INNOVATE, LEARN, AND SCALE RAPIDLY
New Brands & Formats
Technology
Intellectual Property
New Product/Brand Trials
Evaluation and Improvements
Consumer Awareness
Trend Forecasting
Consumer Behaviors
Multi-states Access
Marketing Awareness
Continued Consumer and Patient Feedback
SCALE
32
Highly Effective Execution
Scale SellingSystem
House of Brands
Rapid Innovation Capabilities
THE CRESCO LABS ADVANTAGECAPABILITIES TO DEFEND THE BUSINESS AND DRIVE LONG-TERM VALUE
WHAT WE DO HOW WE DO IT
Top-TierManagement Team
33CRESCO LABS COMPETIT IVE ADVANTAGE
34
DIVERSITY OF TOP-TIER EXPERIENCES ACROSS THE TEAM
SUSTAINABLE FINANCIAL PERFORMANCEQ3 & YTD 2018 FINANCIAL RESULTS
NOTE: EBITDA IS A NON-IFRS MEASURE. PLEASE REFER TO INVESTORS.CRESCOLABS.COM FOR THE DEFINITION
$12.2MREVENUE
+335% YOY
$3.9MNET INCOME
UP COMPARED TO A NET LOSS OF $0.2M IN Q3 2017
$5.3MADJ. EBITDA
UP COMPARED TO ADJUSTED EBITDA OF $0.1M IN Q3 2017
YTD 2018NINE MONTHS ENDED 9/30/18
REVENUE
$25.1MNET INCOME
$6.5MADJ. EBITDA
$8.1M
Q3 2018THREE MONTHS ENDED 9/30/18
+248% YOY UP COMPARED TO A NET LOSS OF $0.9M IN YTD 2017
UP COMPARED TO ADJUSTED EBITDA OF -$0.8M IN YTD 2017
OPPORTUNITY TO EXPAND MULTIPLE
5X
61X
EV/2019 REV
EV/2019 EBITDA
9X
37X
EV/2019 REV
EV/2019 EBITDA
9X
37X
EV/2019 REV
EV/2019 EBITDA
7X
19X
EV/2019 REV
EV/2019 EBITDA
1 . MANAGEMENT ESTIMATES2. CORMARK SECURITIES INC 36
1 2 2 2 2
CRESCO LABS PRO FORMA F INANCIAL
6X
16X
EV/2019 REV
EV/2019 EBITDA
VA
LU
AT
ION
MU
LT
IPL
E
Q&A
THANK YOU
Recommended